Catalyst
Slingshot members are tracking this event:
PDUFA date under priority review for Roche's (RHHBY) Entrectinib in Solid tumors and ROS1-positive non-small cell lung cancer (NSCLC) due August 18, 2019.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 16, 2019
Occurred Source:
https://www.roche.com/investors/updates/inv-update-2019-08-16.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Entrectinib, Solid Tumors, Ros1-, Non-small Cell Lung Cancer, Nsclc
